Alzheimer disease with psychosis: Excess cognitive impairment is restricted to the misidentification subtype

American Journal of Geriatric Psychiatry

Volumn 12, Issue 5, 2004, Pages 449-456

  Perez Madriñan, Gina ^a   Cook, Sarah E ^a,c   Saxton, Judith A ^a   Miyahara, Sachiko ^b   Lopez, Oscar L ^a   Kaufer, Daniel I ^a   Aizenstein, Howard J ^a   DeKosky, Steven T ^a   Sweet, Robert A ^a,d  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF FLORIDA   (United States)

^d UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; AGED; ALZHEIMER DISEASE; APTITUDE TEST; COGNITIVE DEFECT; CONTROLLED STUDY; DELUSIONAL MISIDENTIFICATION; DEPTH PERCEPTION; DISEASE DURATION; DISEASE SEVERITY; EDUCATION; FEMALE; HALLUCINATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PARANOIA; PERSECUTORY DELUSION; PHENOTYPE; PSYCHOSIS; RATING SCALE; REVIEW; SYMPTOMATOLOGY; VERBAL BEHAVIOR;

EID: 84903127113     PISSN: 10647481     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019442-200409000-00003     Document Type: Review

References (37)

1. Sweet RA, Nimgaonkar VL, Devlin B, et al: Psychotic symptoms in Alzheimer disease: evidence for a distinct phenotype. Mol Psychiatry 2003; 8:383-392
2. Sweet RA, Nimgaonkar VL, Devlin B, et al: Increased familial risk of the psychotic phenotype of Alzheimer disease. Neurology 2002; 58:907-911
3. Bacanu SA, Devlin B, Chowdari KV, et al: Linkage analysis of Alzheimer disease with psychosis. Neurology 2002; 59:118-120
4. Sweet RA, Nimgaonkar VL, Kamboh MI, et al: Dopamine receptor genetic variation, psychosis, and aggression in Alzheimer's disease. Arch Neurol 1998; 55:1335-1340
5. 2C receptor polymorphisms and psychopathology in late-onset Alzheimer's disease. Hum Mol Genetics 1998; 7:1507-1509
6. Sweet RA, Panchalingam K, Pettegrew JW, et al: Psychosis in Alzheimer disease: postmortem magnetic resonance spectroscopy evidence of excess neuronal and membrane phospholipid pathology. Neurobiol Aging 2002; 23:547-553
7. Drevets WC, Rubin EH: Psychotic symptoms and the longitudinal course of senile dementia of the Alzheimer type. Biol Psychiatry 1989; 25:39-48
8. Lopez OL, Wisniewski SR, Becker JT, et al: Psychiatric medication and abnormal behavior as predictors of progression in probable Alzheimer disease. Arch Neurol 1999; 56:1266-1272
9. Levy ML, Cummings J, Fairbanks LA, et al: Longitudinal assessment of symptoms of depression, agitation, and psychosis in 181 patients with Alzheimer's disease. Am J Psychiatry 1996; 153:1438-1443
10. Ballard CG, O'Brien JT, Coope B, et al: Psychotic symptoms in dementia and the rate of cognitive decline. J Am Geriatr Soc 1997; 45:1031-1032
11. Paulsen JS, Salmon DP, Thal L, et al: Incidence of and risk factors for hallucinations and delusions in patients with probable Alzheimer's disease. Neurology 2000; 54:1965-1971
12. Tariot PN, Mack JL, Patterson MB, Behavioral Pathology Committee of the Consortium to Establish a Registry for Alzheimer's Disease, et al: The Behavior Rating Scale for Dementia of the Consortium to Establish a Registry for Alzheimer's Disease. Am J Psychiatry 1995; 152:1349-1357
13. Rubin EH, Drevets WC, Burke WJ: Nature of psychotic symptoms in senile dementia of the Alzheimer type. J Geriatr Psychiatry Neurol 1988; 1:17-20
14. Cook SE, Miyahara S, Bacanu SA, et al: Psychotic symptoms in Alzheimer disease: evidence for subtypes. Am J Geriatr Psychiatry 2003; 11:406-413
15. Becker JT, Boller F, Lopez OL, et al: The natural history of Alzheimer's disease: description of study cohort and accuracy of diagnosis. Arch Neurol 1994; 51:585-594
16. Lopez OL, Kamboh MI, Becker JT, et al: The apolipoprotein-E ε4 allele is not associated with psychiatric symptoms or extrapyramidal signs in probable Alzheimer's disease. Neurology 1997; 49:794-797
17. McKhann G, Drachman D, Holstein M, et al: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group Under the Auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34:939-944
18. Mack JL, Patterson MB, Tariot PN: Behavior Rating Scale for Dementia: development of test scales and presentation of data for 555 individuals with Alzheimer's disease. J Geriatr Psychiatry Neurol 1999; 12:211-223
19. Devanand DP, Miller L, Richards M, et al: The Columbia University Scale for Psychopathology in Alzheimer's disease. Arch Neurol 1992; 49:371-376
20. Holstein MF, Holstein SE, McHugh PR: Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12:189-198
21. Rosen WG, Mohs RC, Davis KL: A new rating scale for Alzheimer's disease. Am J Psychiatry 1984; 141:1356-1364
22. Becker JT, Boiler F, Saxton J, et al: Normal rates of forgetting of verbal and non-verbal material in Alzheimer's disease. Cortex 1987; 23:59-72
23. Wechsler D: The Wechsler Memory Scale Manual, Revised. New York, The Psychological Corporation; 1981
24. Benton AL, Hamsher K, Varney NR, et al: Contribution to Neuropsychological Assessment: A Clinical Manual. New York, Oxford University Press, 1983
25. Benton AL: Differential behavioral effects in frontal lobe disease. Neuropsychologia 1968; 6:53-60
26. Stern Y, Mayeux R, Sano M, et al: Predictors of disease course in patients with probable Alzheimer's disease. Neurology 1987; 37:1649-1653
27. Jeste DV, Wragg RE, Salmon DP, et al: Cognitive deficits of patients with Alzheimer's disease with and without delusions. Am J Psychiatry 1992; 149:184-189
28. Rockwell E, Jackson E, Vilke G, et al: A study of delusions in a large cohort of Alzheimer's disease patients. Am J Geriatr Psychiatry 1994; 2:157-164
29. Lopez OL, Becker JT, Brenner RP, et al: Alzheimer's disease with delusions and hallucinations: neuropsychological and electroencephalographic correlates. Neurology 1991; 41:906-912
30. McShane R, Keene J, Gedling J, et al: Do neuroleptic drugs hasten cognitive decline in dementia? Prospective study with necropsy follow-up. BMJ 1997; 314:266-270
31. Paulsen JS, Ready RE, Stout JC, et al: Neurobehaviors and psychotic symptoms in Alzheimer's disease. J Int Neuropsychol Soc 2000; 7:815-820
32. Starkstein SE, Vazquez S, Petracca G, et al: A SPECT study of delusions in Alzheimer's disease. Neurology 1994; 44:2055-2059
33. Mattis S: Mental status examination for organic mental syndrome in the elderly patient, in Geriatric Psychiatry: A Handbook for Psychiatrists and Primary Care Physicians. Edited by Bellak L, Karasu TB. New York, Grune & Stratton, 1976
34. Sultzer DL, Mahler ME, Mandelkern MA, et al: The relationship between psychiatric symptoms and regional cortical metabolism in Alzheimer's disease. J Neuropsychiatry Clin Neurosci 1995; 7:476-484
35. Lopez OL, Smith G, Becker JT, et al: The psychotic phenomenon in probable Alzheimer's disease: a positron-emission tomography study. J Neuropsychiatry Clin Neurosci 2001; 13:50-55
36. Sweet RA, Hamilton RL, Lopez OL, et al: Psychotic symptoms in Alzheimer's disease are not associated with more severe neuropathologic features. Int Psychogeriatr 2000; 12:547-558
37. Sweet RA, Hamilton RL, Healy MT, et al: Alterations of striatal dopamine-receptor binding in Alzheimer's disease are associated with Lewy-body pathology and with antemortem psychosis. Arch Neurol 2001; 58:466-472